CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives
Data(s) |
2014
|
---|---|
Formato |
application/pdf |
Identificador |
http://boris.unibe.ch/67478/1/Seiten_4_aus%20SMW_Suppl-206.pdf Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Swiss medical weekly, 144(Suppl206), 3S-3S. EMH Schweizerischer �rzteverlag doi:10.7892/boris.67478 urn:issn:1424-7860 |
Idioma(s) |
eng |
Publicador |
EMH Schweizerischer �rzteverlag |
Relação |
http://boris.unibe.ch/67478/ |
Direitos |
info:eu-repo/semantics/openAccess |
Fonte |
Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Swiss medical weekly, 144(Suppl206), 3S-3S. EMH Schweizerischer �rzteverlag |
Palavras-Chave | #610 Medicine & health |
Tipo |
info:eu-repo/semantics/conferenceObject info:eu-repo/semantics/publishedVersion PeerReviewed |